When Patients Present With Direct-to-Consumer Pharmacogenomic Test Results
A 65-year-old woman with hypertension, hyperlipidemia, and occasional anxiety (untreated) presents to her primary care provider (PCP) with direct-to-consumer genetic test (DTC-GT) results. She is status post acute coronary syndrome with percutaneous coronary intervention 2 weeks ago. Her prescription medications include aspirin 81 mg daily, metoprolol 50 mg twice daily, clopidogrel 75 mg daily, simvastatin 20 mg daily, and lisinopril 10 mg daily. For her birthday, her daughter gave her a DTC-GT kit.
